We lead the synthetic biology industry, having developed and successfully commercialized the most Lab-to-Market™ ingredients. Our sustainable ingredients are used in thousands of top global brands, including our own family of consumer brands in Clean Beauty and Health markets.
As part of our mission to make renewables mainstream, our Board is lead by individuals with impressive business and industry credentials, several of which hold significant ownership stakes in Amyris directly or via their companies or affiliated entities.
John Doerr is Chairman at Kleiner Perkins, a venture capital firm, since 1980. Mr. Doerr currently serves on the board of directors of Alphabet and DoorDash. He previously served as a director of Amazon, Bloom Energy, Coursera, Quantumscape and Zynga Inc. Mr. Doerr holds a Bachelor of Science and a Master of Science in Electrical Engineering degrees from Rice University and a Master of Business Administration degree from Harvard University.
Ana Dutra is an experienced CEO, business advisor and corporate board director of publicly-traded, family-owned and private corporations. She is a Latina leader with over 30 years of experience in P&L management, deals structuring, digital technology, business growth and C-Level business advisory in over 25 countries. She has deep experience in ESG, digital technology, e-commerce, ERP systems and has a CERT Certification in Cybersecurity Oversight by Carnegie Mellon University and the National Association of Corporate Directors.
Ms. Dutra serves as Director on the boards of the CME Group, Eletropar and First Internet Bancorp.
As a CEO, Ms. Dutra has led several global and cross-border acquisitions, joint-ventures, partnership agreements and M&A integrations. In her own tenure as CEO and P&L leader with companies such as IBM, CSC, Marsh & McLennan, Accenture and Korn/Ferry International, Ms. Dutra created several $500+ MM global businesses through the combination of organic growth, global acquisitions and joint-ventures, innovative go-to-market approaches and incorporation of technology and digital transformation of services and products.
Ms. Dutra holds an MBA from Kellogg at Northwestern University, a Masters in Economics from Pontificia Universidade do Rio de Janeiro, a Juris Doctor from Universidade do Estado do Rio de Janeiro.
Chair of the Nominating and Governance Committee
Member of the Leadership, Development, Inclusion and Compensation Committee
Dr. Duyk is partner at Circularis Partners, an investment firm focused on supporting technology-enabled companies that advance the circular economy, promote sustainability, and enhance resource efficiency. Prior to Circularis, Dr. Duyk was the managing director and partner of TPG Alternative & Renewable Technologies (ART)/TPG Biotechnology from 2004 to 2017. Prior to joining TPG, Dr. Duyk served on the Board of Directors and was President of Research and Development at Exelixis. Prior to Exelixis, he was one of the founding scientific staff at Millennium Pharmaceuticals and served as Vice President of Genomics. Prior to his tenure at Millennium, Dr. Duyk was an Assistant Professor at Harvard Medical School (HMS) in the Department of Genetics, and an Assistant Investigator of the Howard Hughes Medical Institute (HHMI). While at HMS, Dr. Duyk was a Co-Principal Investigator in the National Institutes of Health (NIH) funded Cooperative Human Linkage Center. Dr. Duyk holds a Ph.D. and M.D. from Case Western Reserve University. He completed his medical and fellowship training at the University of California, San Francisco. While at UCSF, Dr. Duyk was a fellow of the Lucille P. Markey Foundation and was also awarded a post-doctoral fellowship from HHMI. He is a Fellow of the American Association for the Advancement of Science. Dr. Duyk currently serves on the Board of Directors of Anuvia Plant Nutrients; Concentric Ag; and Regen. He is a trustee of Case Western Reserve University where he Chairs the finance committee and is a member of the executive committee and investment committee. Dr. Duyk is also a member of the Institute Board of Directors of the Moffitt Cancer Center where he Chairs the R&D committee. He serves as Chairman of the Board of OncoBay Clinical, a private contract research organization and subsidiary of Moffitt Cancer Center. Dr. Duyk previously served on the Board of Directors of the American Society of Human Genetics (ASHG) where he is currently a member of the organization’s finance committee and Chairs the investment committee. He is a member of the Scientific Advisory Board (SAB) for Lawrence Berkeley National Lab (DOE) and a member of the Advisory Board for Innovatus Capital Partners. Previously, he served as a member of the SAB for Bayer CropSciences, Jackson Labs, as well as numerous NIH advisory committees. Dr. Duyk serves or has served as an advisor (e.g. Qiming Ventures, Grove BioPharma, etc.) or board member to a number of seed stage biotechnology companies.
Member of the Audit Committee
Dr. Kung is a founding member of Vivo, a global healthcare investment firm founded in 1996 in Palo Alto, California. Dr. Kung started his career in the biotechnology industry in 1979 when he joined Cetus Corporation. He later co-founded Cetus Immune Corporation in 1981, which was acquired by its parent company in 1983. In 1983 he co-founded Genelabs Technologies, Inc. where he served as Chairman and CEO until 1995. During his tenure in Genelabs, he brought the company public in 1991, and built it to a 175 employee international biotech company with operations in the United States, Belgium, Singapore, Switzerland and Taiwan. Dr. Kung holds a Bachelor of Science degree in chemistry from the National Tsing Hua University in Taiwan, and a Doctor of Philosophy degree in molecular biology and a Master of Business Administration degree from the University of California, Berkeley. Dr. Kung currently serves on the board of directors of a number of healthcare and biotechnology companies.
Mr. McCann is the founder and Chairman of the board of directors of 1-800-FLOWERS.COM, Inc., a floral and gourmet foods gift retailer and distribution company founded in 1976, and served as chief executive officer of 1-800-FLOWERS.COM, Inc. from 1976 until June 2016. Mr. McCann also serves on the board of directors of International Game Technology PLC and has previously served on the board of directors of Willis Towers Watson PLC and The Scotts Miracle-Gro Company.
Chair of the Leadership, Development, Inclusion and Compensation Committee
Member of the Nominating and Governance Committee
Mr. Mills has more than 40 years of experience in the fields of accounting, corporate finance, strategic planning, risk management, and mergers and acquisitions. He served as Chief Financial Officer of the Company from May 2012 to December 2013. Prior to joining the Company, Mr. Mills had a 33-year career at Archer-Daniels-Midland Company (“ADM”), one of the world’s largest agricultural processors and food ingredient providers. At ADM, he held various senior executive roles, including Chief Financial Officer, Controller, and head of Global Strategic Planning. Since 2013, Mr. Mills has served as a consultant and advisor to clients in the private equity, agribusiness, and financial services fields. Mr. Mills currently serves on the boards of Black Hills Corporation (where he serves as chair of the board), Farmers Edge, Inc., Illinois College (where he also serves as Chair of the board), First Illinois Corporation (along with its wholly-owned banking subsidiary, Hickory Point Bank & Trust) and Arianna S.A. Mr. Mills holds a Bachelor of Science degree in Mathematics from Illinois College.
Chair of the Audit Committee
Member of the Leadership, Development, Inclusion and Compensation Committee
Ryan Panchadsaram is a partner at Foris Ventures and serves as an advisor to the Chairman at Kleiner Perkins. He has been in the role since 2016 and invests in bold founders and disruptive technologies that are tackling the climate crisis, fixing our healthcare system, and improving the way we live and work. Prior to Kleiner Perkins, Mr. Panchadsaram worked at the White House and served as the deputy chief technology officer for the United States. He helped shape how an $80 billion IT budget could be used by federal agencies to deliver on their missions in a more effective, user-centric, and datadriven way. In 2015, he served as a delegate to the United Nations to launch the Solutions Summit, a grassroots effort to spotlight the work of exceptional innovators around the world tackling the Sustainable Development Goals. In 2013, he was part of the crisis response team that rescued HealthCare.gov.
This was a multi-month effort that ultimately led to the Affordable Care Act providing healthcare to 31 million people. Prior to government service, he was a health technology entrepreneur and worked at Microsoft and Salesforce.com. Mr. Panchadsaram holds a Bachelor of Science degree in Industrial Engineering and Operations Research from U.C. Berkeley.
Lisa has pioneered the development of feminine Chinese brands for Daling Family. She partnered with former Estee Lauder CTO, Harvey Gedeon and award-winning Harvard Medical School skin management expert Dr. Rothaus, founding La Nature Research Center in New York. Together they created the Native Beauty skin wellness line. With Rosa Dwyer, ex-chief of formula for Estée Lauder Group, she developed Color Lock – a wellness line specially formulated for Chinese women's skin. Prior to Daling, Lisa served as Brand Director of Dupont Lycra (Hong Kong & China) and lead it to its current top-of-market position in China. She then served as the youngest Chief Representative of YSL China in France in the company’s history.
Member of the Nominating and Governance Committee
M Freddie Reiss retired from his role as Senior Managing Director in the Corporate Finance/Restructuring practice of FTI Consulting, Inc. in 2013. Mr. Reiss has over 30 years of experience in strategic planning, cash management, liquidation analysis, covenant negotiations, forensic accounting and valuation. He specializes in advising on bankruptcies, reorganizations, business restructuring and in providing expert witness testimony for underperforming companies. Prior to joining FTI Consulting, Mr. Reiss was a partner and west region leader at PricewaterhouseCoopers, LLP, where he co-founded the Business Restructuring Services practice. Mr. Reiss is a recognized expert in the field of financial restructuring. Mr. Reiss holds an M.B.A. from City College of New York’s Baruch College and a B.B.A. from City College of New York’s Bernard Baruch School of Business. He is a Certified Public Accountant in New York and California. Mr. Reiss currently serves as an independent director of both Woodbridge Wind-Down Entity LLC, and its parent, Woodbridge Liquidation Trust, on which he is also the Chair of the Audit Committee, and both Blackrock TCP Capital Corp., on which he is also Chair of the Audit Committee, member of the Governance and Compensation Committee and a member of the Joint Transactions Committee, and Blackrock Direct Lending Corp., on which is also the Chair of Audit Committee and a member of the Joint Transactions Committee Member. Since April 2023, he has been serving as an independent director for Peer Street, Inc. He is also on the Board of Trustees for the Baruch College Fund, and was chairman of the audit committee and independent board member for Contech Engineered Solutions and Managing Member and director of Variant Holdings LLC.
Julie Spencer Washington is an accomplished senior executive with a distinguished career in marketing spanning leading companies like Trinity Health, Champion Petfoods, Procter & Gamble, Gillette, Nestlé Purina, Jamba Juice, and Luxottica. In each of her leadership positions, Julie has driven sustainable corporate growth and profitability through a keen understanding of consumer needs and behaviors, market dynamics and digital trends (including social media). Julie has also leveraged her special gift for developing and motivating high-performing teams to further impact corporate success. Currently, Julie serves as Chief Marketing, Communications & Customer Experience Officer at Trinity Health, a Catholic health care delivery system that serves more than 30 million people across 25 states. She is responsible for the strategic leadership of marketing, brand building, demand creation, internal and crisis communications and community engagement. Julie is committed to community improvement and, in parallel with her professional responsibilities, has a long, varied history of board service. Julie’s professional and community accomplishments have earned national attention, including selection of Diversity Woman Media's "The Elite 100" (2022), Savoy magazine’s “Top 100 Most Influential Blacks in Corporate America” (2022, 2020, 2018), and Millennium Alliance's "Digital Healthcare Innovator of the Year" (2021). Julie holds a Master of Business Administration degree from Washington University, a Bachelor of Arts degree in Chemistry and Psychology from Emory University, and an Executive in Education Certificate on Driving Digital and Social Strategy from Harvard University. A champion of diversity and inclusion, Julie has helped companies build more effective teams.
Member of the Audit Committee & Leadership, Development, Inclusion and Compensation Committee
Mr. White is currently President and Chief Executive Officer of Edsal Manufacturing, a leading designer, manufacturer and distributor of high-quality steel shelving and cabinets, where he has served since 2019. Mr. White has over 30 years of experience in global finance, marketing and general management roles. Prior to joining Edsal, from 2016 to 2019, Mr. White served as CEO of New Avon, a leading provider of cosmetics and beauty products. Prior to that, from 2005 to 2016, he held multiple senior management roles over 10 years at Abbott Laboratories, including President of Abbott Nutrition International. Mr. White began his career at Procter & Gamble where he served for 15 years. Mr. White currently serves as a member of the board of directors of Edsal, a privately held company. Mr. White holds an M.B.A. from Northwestern University Kellogg School of Management and a B.S. in Finance from Miami University.